Price
$162.07-11.61%Social Signal Score
Analyst Ratings
5 analystsRevenue
$210.75M+35623.64%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Thomas T. Vo
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 1,037
- Beta
- 2.02
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 4.41
Financials
Revenue
$210.75M+35623.6%Net Income
$65.84MEBITDA
$127.07MFree Cash Flow
$31.66M+50138.0%EPS (diluted)
$9.38Shares Outstanding (diluted)
7.02M+1327168.1%Operating Expenses
$19.56MCash & Debt
$205.21MReturn of Capital
$32.22MRevenue by Segment (annual)
$449.06MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $875.26M | $70.79M | $11.13 |
| 2024 | $479.95M | $52.18M | $10.23 |
| 2023 | $247.65M | $-45.79M | $-10.39 |
| 2022 | $219.29M | $-424.78M | $-100.50 |
| 2021 | $331.53M | $132.59M | $33.55 |
| 2020 | $274.03M | $105.97M | $24.69 |
| 2019 | $97.06M | $20.92M | $4.88 |
| 2018 | $1.37M | $-2.81M | $-0.02 |
| 2017 | $23.2K | $582.1K | $-0.07 |
| 2016 | $0.00 | $-7.43M | $-3.60 |
| 2015 | $0.00 | $83.8K | $0.04 |
| 2014 | $1.07M | $-684.3K | $-2250.00 |
| 2013 | $1.46M | $250.5K | $750.00 |
| 2012 | $1.59M | $-1.62M | $-5250.00 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $16.35
- Implied price
- $245.26
- Return from $216.50
- 2.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $121.94 — -43.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 11 | 13 | 15 | 17 | 19 |
|---|---|---|---|---|---|
| -2.0% | -12.6% | -9.6% | -7.0% | -4.6% | -2.5% |
| 3.0% | -8.1% | -5.0% | -2.2% | 0.3% | 2.5% |
| 8.0% | -3.6% | -0.4% | 2.5% | 5.1% | 7.5% |
| 13.0% | 0.8% | 4.2% | 7.3% | 10.0% | 12.5% |
| 18.0% | 5.3% | 8.9% | 12.0% | 14.9% | 17.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+0.00%Social Signal Score
Mentions (12)
- Newszacks.com·4d ago·Positive
Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns Let's take a look at four stocks, NUTX, RCMT, TILE and QUAD, with impressive net profit margins for a robust portfolio.
View source ↗ - Newsseekingalpha.com·10d ago·Neutral
Nutex Health: A High-Risk, High-Reward Play For Speculative Investors Nutex Health has surged 134% since April, driven by its out-of-network micro-hospital model and expanding margins. It has staged a turnaround in 2026, driven by strong EPS growth after years of struggle. The company leverages the No Surprises Act's arbitration process to sustain margins against insurer underpayment, making dispute resolution central to its current business.
View source ↗ - Newszacks.com·24d ago·Neutral
What Makes Nutex Health (NUTX) a Good Fit for 'Trend Investing' Nutex Health (NUTX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
View source ↗ - Newsprnewswire.com·25d ago·Neutral
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT HOUSTON, Sept. 10, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today provided an update regarding its previously announced cybersecurity event.
View source ↗ - Newsprnewswire.com·34d ago·Neutral
Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data Free case evaluations for individuals affected by the Nutex Health cyberattack claimed by The Gentlemen ransomware group HOUSTON, Sept. 1, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a cyberattack on Nutex Health Inc. (NASDAQ: NUTX).
View source ↗ - Newszacks.com·35d ago·Positive
Nutex Health Inc. (NUTX) is a Great Momentum Stock: Should You Buy? Does Nutex Health Inc. (NUTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newsprnewswire.com·36d ago·Neutral
…h Hospitals Earn Multiple Community Honors in Second Quarter 2026 HOUSTON, Aug. 31, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the awards and honors earned by its hospitals during the second quarter of 2026. Nutex Health hospi…
View source ↗ - Newszacks.com·40d ago·Neutral
Here's Why 'Trend' Investors Would Love Betting on Nutex Health (NUTX) Nutex Health (NUTX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
View source ↗ - Newszacks.com·41d ago·Neutral
Surging Earnings Estimates Signal Upside for Nutex Health (NUTX) Stock Nutex Health Inc. (NUTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
View source ↗ - Newsprnewswire.com·42d ago·Negative
…ost Rates" in Federal QPA Calculations Under the No Surprises Act HOUSTON, Aug. 25, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated health care delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states, as well as primary care-centric, risk-bearing physician networks, today commented on a recent ruling by the U.S. Court of Appeals for the Fifth Circuit invalidating key por…
View source ↗ - Newsseekingalpha.com·54d ago·Positive
Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade) Nutex Health upgraded to "Strong Buy" as margin expansion and patient volume growth drive bullish outlook. Despite a 13% YoY revenue decline, Q2 saw 9.6% patient volume growth and significant, sustainable operating cost reductions. CMS administrative fee cuts and the HaloMD contract amendment are expected to lower normalized costs by 25%–30% in future periods.
View source ↗ - Newsseekingalpha.com·59d ago·Positive
Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript Nutex Health Inc. (NUTX) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Tue, Nov 17(in 6 weeks)
Consensus estimate $5.71 per share
Typical surprise +63.4% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$9.38 vs $4.95beat
- Thu, Apr 30$6.52 vs $3.99beat
- Thu, Mar 5$1.61 vs $5.56miss
- Wed, Nov 19$7.76 vs $1.81beat
- Wed, Oct 22$-2.95 vs $-1.43miss
- Tue, May 13$2.56 vs $3.04miss
Estimates and results for NUTX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NUTX officers and directors.
- Bought
- $393k
- Sold
- $43k
16 trades
1 trade
- Saunders Scott Jsold
- Jaumot Frank Ebought
- Hosseinion Warrenbought
- Spears Kelvinbought
- Montgomery Pamela W.bought
- Bates Jon Christianbought
- Bates Jon Christianbought
- Dogan Meeshanthinibought
83 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NUTX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.